Home
Complement System
Classical Pathway
Complement Therapeutic Target-C1 Complex
Complement Therapeutic Target-C1 Inhibitor
Complement Therapeutic Target-C2
Complement Therapeutic Target-C3
Complement Therapeutic Target-C4
Complement Therapeutic Target-C5
Complement Therapeutic Target-C5aR
Complement Therapeutic Target-C3 Convertases
Complement Therapeutic Target-C5 Convertases
Lectin Pathway
Complement Therapeutic Target-MASP-1
Complement Therapeutic Target-MASP-2
Alternative Pathway
Complement Factor B
Complement Factor D
Complement Factor P
Membrane Attack Complex
Complement Therapeutic Target-C6
Complement Therapeutic Target-C7
Complement Therapeutic Target-C8
Complement Therapeutic Target-C9
Indication
Autoimmune Disease
Systemic Lupus Erythematosus-like Syndrome
Hashimoto's Disease
Systemic Sclerosis
Rheumatoid Arthritis
Nephropathy
Glomerulonephritis
Hemolytic Uremic Syndrome
C3 Glomerulopathy
Osteology
Periodontal Ehlers-Danlos Syndrome
Genetic Disease
Hereditary Angioedema
Acquired Angioedema
Infection
Recurrent Infection
Septic Shock
Meningococcal Meningitis
Primary Amebic Meningoencephalitis
Chemotherapy-induced Neutropenia
Neurology
Alzheimer's Disease
Inflammatory Disease
Pyoderma Gangrenosum
Salpingo-Oophoritis
Ophthalmology
Age-Related Macular Degeneration
Anterior Uveitis
Cardiovascular Disease
Subacute Myocardial Infarction
Acute Ischemic Stroke
Services
Therapeutic Antibody Development
Drug Development Service for C5
Drug Development Service for CD20
Drug Development Service for CD46 (MCP)
Drug Development Service for CD55 (DAF)
Drug Development Service for CD59 (MIRL)
Complement Component Inhibitor Development
Aptamer Development Service
One-stop Aptamer
In Vitro
Selection Services
Aptamer-Based Conjugation Services
Aptamer Modifications Services
Aptamer Characterization Services
Aptamer
In Vitro
Analysis Services
Aptamer-Based ELONA Assay Development Service
Complement Test Services
Complement Function/Activity Test
Total Complement Activity Test
Individual Components Activity Test
Complement Activation Products Test
Hemolytic Inhibition Assay
Complement Inhibitor Validation
Receptor Ligand Binding Assay
Cell-based Complement Activity Assay
Complement Autoantibody Test
Complement Genetic Test
Complement Multiplex Assay
Products
Antibodies
Proteins
Assay Kits
Peptides
Inhibitors
Sera and Plasmas
Vectors
Lysates
Reagents
Aptamers
Support
Complement System Knowledge Center
Featured Services
Research Highlights
Brochure Download Center
Protocols
Podcast
Contact Us
Contact Us
About Us
Careers
Online Inquiry
Events
Product Search
Service Search
Keywords Search
Home
Support
Protocols
By Target
Complement C3 Related Protocols
Complement C3 Related Protocols
Click the following items to find C3 Related Assay.
1
C3 Purification from Human Plasma Protocol
2
C3 Analysis by Hemolysis Assay Protocol
For Research Use Only.
Related Sections:
Complement C1q Related Protocols
Complement C1r and C1s Related Protocols
Complement C4 Related Protocols
Complement C2 Related Protocols
Anaphylatoxin C3a Related Protocols
Anaphylatoxin C4a Related Protocols
Complement C5 Related Protocols
Anaphylatoxin C5a Related Protocols
Complement C5b-9 Related Protocols
Complement C6 Related Protocols
Complement C7 Related Protocols
Complement C8 Related Protocols
Complement C9 Related Protocols
Complement Factor B Related Protocols
Complement Factor D Related Protocols
Complement Factor H Related Protocols
Complement Factor I Related Protocols
Complement Factor Properdin Related Protocols
MCP/CD46 Related Protocols
DAF/CD55 Related Protocols
CD59 Related Protocols
Clusterin Related Protocols
C1 Inhibitor (C1-INH) Related Protocols
C4b-Binding Protein (C4BP) Related Protocols
CR1/CD35 Related Protocols
CR2/CD21 Related Protocols
CR3 (CD11b/CD18) Related Protocols
CR4 (CD11c/CD18) Related Protocols
C5aR (CD88) Related Protocols
Complement C1q Receptor Related Protocols
Mannan-Binding Lectins Related Protocols
MASP-1 and MASP-2 Related Protocols
Ficolins Related Protocols
Surfactant Protein A (SP-A) Related Protocols
Surfactant Protein D (SP-D) Related Protocols
C3 Purification from Human Plasma Protocol
C3 Analysis by Hemolysis Assay Protocol
Support
Complement System Knowledge Center
Complement System Composition
Featured Services
Complement Testing Services
Research Highlights
Activation of the Complement System by Urban Particulate Matter
Adipsin Is a Potential Predictor for Preeclampsia in Early Pregnancy
Alternative C3 Complement System: Lipids and Atherosclerosis
Antimicrobial Peptide as Complement System Modulator
Autoantibodies Against the Complement Regulator Factor H in the Serum of Patients
C4b Binding Protein Acts as an Innate Immune Effector Against Influenza A Virus
Coagulation Complement Activation and Cerebral Hypoperfusion
Complement Activation in the Central Nervous System
Complement Pathway Activation Is Associated With COVID-19 Mortality
Complement C4 Is Reduced in iPSC-Derived Astrocytes of Autism Subjects
Complement DAF is a modulator of influenza A virus lung immunopathology
Complement Regulation in Human Tenocytes under the Influence of Anaphylatoxin C5a
Dendrimer end-terminal motif-dependent evasion of complement activation
Inhibition of complement C5a receptor protects lung cells and tissues
Interference of the Zika Virus E-Protein With the MAC of the Complement System
Lectin Pathway Mediates Complement Activation by SARS-CoV-2 Proteins
Microglial trogocytosis and the complement system regulate axonal pruning in vivo
Modulation of complement activation by pentraxin-3 in prostate cancer
Monitoring of the Complement System Status in Patients
Monoclonal Antibodies Capable of Inhibiting Complement Downstream of C5
REV-ERBα mediates complement expression and diurnal regulation of phagocytosis
SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation
Specific Evolution and Gene Family Expansion of C3 and Regulatory CFH in Fish
Syk facilitates phagosome-lysosome fusion by regulating actin-remodeling
The allosteric modulation of complement C5 by knob domain peptides
The solution structure of the complement deregulator FHR5 reveals a compact dimer
Two human antibodies enhance binding of CFH by stabilizing the CFH binding site
Brochure Download Center
Protocols
Podcast
Complement Podcast
Online Inquiry
Name
* Phone
* Email
* Products or Services Interested:
Project Description
Send